Literature DB >> 18037142

Elimination of rat spinal substance P receptor bearing neurons dissociates cardiovascular and nocifensive responses to nicotinic agonists.

Imran M Khan1, Chris V Wart, Erin A Singletary, Shanaka Stanislaus, Tom Deerinck, Tony L Yaksh, Morton P Printz.   

Abstract

Intrathecal (IT) delivery of nicotinic agonists evokes dose dependent nocifensive behavior and cardiovascular responses. Previous studies suggested that these effects may be attenuated by the loss of substance P positive (sP(+)) primary afferents. To further characterize these cell systems, we examined the effect of selectively destroying neurokinin 1 receptor bearing (NK1-r(+)) dorsal horn neurons on IT nicotinic agonist evoked responses. In the dorsal spinal cord, confocal immunohistochemical microscopy revealed that nAChR subunits (alpha3, alpha4, alpha5, beta2 and beta4), NeuN B (neuronal marker) and NK1-r were all co-expressed in the superficial dorsal horn; however alpha3, alpha5, beta2 and beta4 exhibited the highest degree of colocalization with NK1-r expressing neurons. After intrathecal substance P-saporin (sP-SAP), NK1-r(+) cell bodies and dendrites in the superficial dorsal horn were largely abolished. The greatest loss in co-expression of nAChR subunits with NK1-r was observed with alpha3, alpha5, beta2 and beta4 subunits. Following intrathecal sP-SAP, the nocifensive responses to all nicotinic agonists were reduced; however, in contrast, while cardiovascular responses evoked by IT nicotine were unaltered, IT cytisine and epibatidine exhibited enhanced tachycardia and pressor responses. These results indicate subunit-specific relationships between the NK1-r and nicotinic receptor systems. The loss of nocifensive activity after destruction of the NK1-r bearing cells in spite of the persistence of nicotinic subunits on other cells, emphasizes the importance of the superficial marginal neuron in mediating these nicotinic effects. Further, the exaggerated cardiovascular responses to cytisine following loss of NK1-r bearing cells suggest the presence of a nicotinic receptor-mediated stimulation of inhibitory circuits at the spinal level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037142      PMCID: PMC4418974          DOI: 10.1016/j.neuropharm.2007.09.014

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  29 in total

1.  A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.

Authors:  I M Khan; S Stanislaus; L Zhang; P Taylor; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

2.  Studies on the direct spinal action of narcotics in the production of analgesia in the rat.

Authors:  T L Yaksh; T A Rudy
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

3.  Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor.

Authors:  P W Mantyh; S D Rogers; P Honore; B J Allen; J R Ghilardi; J Li; R S Daughters; D A Lappi; R G Wiley; D A Simone
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

4.  The rat spinal cord slice: Its use in generating pharmacological evidence for cholinergic transmission using the alpha7 subtype of nicotinic receptors in the central autonomic nucleus.

Authors:  Amyaouch Bradaïa; Riad Seddik; Rémy Schlichter; Jérôme Trouslard
Journal:  J Pharmacol Toxicol Methods       Date:  2005 May-Jun       Impact factor: 1.950

5.  Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways.

Authors:  Rie Suzuki; Sara Morcuende; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

6.  Neurokinin-1 receptor immunoreactivity in hypotension sensitive sympathetic preganglionic neurons.

Authors:  K J Burman; D J McKitrick; J B Minson; A West; L F Arnolda; I J Llewellyn-Smith
Journal:  Brain Res       Date:  2001-10-12       Impact factor: 3.252

7.  Evidence for spinal dorsal horn hyperexcitability in rats following sustained morphine exposure.

Authors:  Rie Suzuki; Frank Porreca; Anthony H Dickenson
Journal:  Neurosci Lett       Date:  2006-09-07       Impact factor: 3.046

8.  Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron.

Authors:  Gregory O Dussor; Gabriela Helesic; Kenneth M Hargreaves; Christopher M Flores
Journal:  Pain       Date:  2004-01       Impact factor: 6.961

9.  Vesicular glutamate transporters in the spinal cord, with special reference to sensory primary afferent synapses.

Authors:  Francisco J Alvarez; Rosa M Villalba; Ricardo Zerda; Stephen P Schneider
Journal:  J Comp Neurol       Date:  2004-05-03       Impact factor: 3.215

10.  Spinal interneurons infected by renal injection of pseudorabies virus in the rat.

Authors:  Xiaorui Tang; Nathan D Neckel; Lawrence P Schramm
Journal:  Brain Res       Date:  2004-04-09       Impact factor: 3.252

View more
  3 in total

1.  Metabotropic glutamate receptor 5 regulates excitability and Kv4.2-containing K⁺ channels primarily in excitatory neurons of the spinal dorsal horn.

Authors:  Hui-Juan Hu; Robert W Gereau
Journal:  J Neurophysiol       Date:  2011-03-30       Impact factor: 2.714

2.  Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress.

Authors:  Britta Veitenheimer; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-01       Impact factor: 3.619

3.  Spinal alpha3beta2* nicotinic acetylcholine receptors tonically inhibit the transmission of nociceptive mechanical stimuli.

Authors:  Tracey Young; Shannon Wittenauer; J Michael McIntosh; Michelle Vincler
Journal:  Brain Res       Date:  2008-07-02       Impact factor: 3.252

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.